{
  "DOI": "10.1038/ejhg.2013.198",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2013.198",
  "alternative-id": [
    "BFejhg2013198"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Rousseau",
      "given": "Julie",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Gioia",
      "given": "Roberta",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Layrolle",
      "given": "Pierre",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lieubeau",
      "given": "Blandine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Heymann",
      "given": "Dominique",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rossi",
      "given": "Antonio",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Marini",
      "given": "Joan C",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Trichet",
      "given": "Valerie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Forlino",
      "given": "Antonella",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2013,
        9,
        11
      ]
    ],
    "date-time": "2013-09-11T10:19:27Z",
    "timestamp": 1378894767000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T17:09:18Z",
    "timestamp": 1684429758000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        12
      ]
    ],
    "date-time": "2024-04-12T22:36:40Z",
    "timestamp": 1712961400348
  },
  "is-referenced-by-count": 20,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "5",
  "issued": {
    "date-parts": [
      [
        2013,
        9,
        11
      ]
    ]
  },
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          2014,
          5
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2013,
            9,
            11
          ]
        ],
        "date-time": "2013-09-11T00:00:00Z",
        "timestamp": 1378857600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2013198.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2013198",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2013198.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "667-674",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2013,
        9,
        11
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2013,
        9,
        11
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2014,
        5
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1073/pnas.1231012100",
      "author": "VM Miller",
      "doi-asserted-by": "publisher",
      "first-page": "7195",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2013198_CR1",
      "unstructured": "Miller VM, Xia H, Marrs GL et al: Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci USA 2003; 100: 7195–7200.",
      "volume": "100",
      "year": "2003"
    },
    {
      "DOI": "10.1038/35888",
      "author": "A Fire",
      "doi-asserted-by": "publisher",
      "first-page": "806",
      "journal-title": "Nature",
      "key": "BFejhg2013198_CR2",
      "unstructured": "Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC : Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806–811.",
      "volume": "391",
      "year": "1998"
    },
    {
      "DOI": "10.1126/science.286.5441.950",
      "author": "AJ Hamilton",
      "doi-asserted-by": "publisher",
      "first-page": "950",
      "journal-title": "Science",
      "key": "BFejhg2013198_CR3",
      "unstructured": "Hamilton AJ, Baulcombe DC : A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 1999; 286: 950–952.",
      "volume": "286",
      "year": "1999"
    },
    {
      "DOI": "10.1046/j.1474-9728.2003.00054.x",
      "author": "H Ding",
      "doi-asserted-by": "publisher",
      "first-page": "209",
      "journal-title": "Aging Cell",
      "key": "BFejhg2013198_CR4",
      "unstructured": "Ding H, Schwarz DS, Keene A et al: Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2003; 2: 209–217.",
      "volume": "2",
      "year": "2003"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201230",
      "author": "S Millington-Ward",
      "doi-asserted-by": "publisher",
      "first-page": "864",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg2013198_CR5",
      "unstructured": "Millington-Ward S, McMahon HP, Allen D et al: RNAi of COL1A1 in mesenchymal progenitor cells. Eur J Hum Genet 2004; 12: 864–866.",
      "volume": "12",
      "year": "2004"
    },
    {
      "DOI": "10.7150/ijms.5.361",
      "author": "K Lindahl",
      "doi-asserted-by": "publisher",
      "first-page": "361",
      "journal-title": "Int J Med Sci",
      "key": "BFejhg2013198_CR6",
      "unstructured": "Lindahl K, Rubin CJ, Kindmark A, Ljunggren O : Allele dependent silencing of COL1A2 using small interfering RNAs. Int J Med Sci 2008; 5: 361–365.",
      "volume": "5",
      "year": "2008"
    },
    {
      "DOI": "10.1096/fj.08-110890",
      "author": "RD Klootwijk",
      "doi-asserted-by": "publisher",
      "first-page": "3846",
      "journal-title": "Faseb J",
      "key": "BFejhg2013198_CR7",
      "unstructured": "Klootwijk RD, Savelkoul PJ, Ciccone C et al: Allele-specific silencing of the dominant disease allele in sialuria by RNA interference. Faseb J 2008; 22: 3846–3852.",
      "volume": "22",
      "year": "2008"
    },
    {
      "DOI": "10.1371/journal.pone.0049757",
      "author": "RE Loy",
      "doi-asserted-by": "publisher",
      "first-page": "e49757",
      "journal-title": "PLoS One",
      "key": "BFejhg2013198_CR8",
      "unstructured": "Loy RE, Lueck JD, Mostajo-Radji MA, Carrell EM, Dirksen RT : Allele-specific gene silencing in two mouse models of autosomal dominant skeletal myopathy. PLoS One 2012; 7: e49757.",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.1126/science.1068999",
      "author": "TR Brummelkamp",
      "doi-asserted-by": "publisher",
      "first-page": "550",
      "journal-title": "Science",
      "key": "BFejhg2013198_CR9",
      "unstructured": "Brummelkamp TR, Bernards R, Agami R : A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550–553.",
      "volume": "296",
      "year": "2002"
    },
    {
      "DOI": "10.1101/gad.981002",
      "author": "PJ Paddison",
      "doi-asserted-by": "publisher",
      "first-page": "948",
      "journal-title": "Genes Dev",
      "key": "BFejhg2013198_CR10",
      "unstructured": "Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS : Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002; 16: 948–958.",
      "volume": "16",
      "year": "2002"
    },
    {
      "DOI": "10.1038/nrendo.2011.81",
      "author": "A Forlino",
      "doi-asserted-by": "publisher",
      "first-page": "540",
      "journal-title": "Nat Rev Endocrinol",
      "key": "BFejhg2013198_CR11",
      "unstructured": "Forlino A, Cabral WA, Barnes AM, Marini JC : New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol 2011; 7: 540–557.",
      "volume": "7",
      "year": "2011"
    },
    {
      "DOI": "10.1002/humu.20429",
      "author": "JC Marini",
      "doi-asserted-by": "publisher",
      "first-page": "209",
      "journal-title": "Hum Mutat",
      "key": "BFejhg2013198_CR12",
      "unstructured": "Marini JC, Forlino A, Cabral WA et al: Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 2007; 28: 209–221.",
      "volume": "28",
      "year": "2007"
    },
    {
      "author": "E Monti",
      "first-page": "367",
      "journal-title": "Ther Clin Risk Manag",
      "key": "BFejhg2013198_CR13",
      "unstructured": "Monti E, Mottes M, Fraschini P et al: Current and emerging treatments for the management of osteogenesis imperfecta. Ther Clin Risk Manag 2010; 6: 367–381.",
      "volume": "6",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s11154-008-9074-4",
      "author": "MS Cheung",
      "doi-asserted-by": "publisher",
      "first-page": "153",
      "journal-title": "Rev Endocr Metab Disord",
      "key": "BFejhg2013198_CR14",
      "unstructured": "Cheung MS, Glorieux FH : Osteogenesis imperfecta: update on presentation and management. Rev Endocr Metab Disord 2008; 9: 153–160.",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1002/jbmr.1717",
      "author": "BP Sinder",
      "doi-asserted-by": "publisher",
      "first-page": "73",
      "journal-title": "J Bone Miner Res",
      "key": "BFejhg2013198_CR15",
      "unstructured": "Sinder BP, Eddy MM, Ominsky MS, Caird MS, Marini JC, Kozloff KM : Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfecta. J Bone Miner Res 2013; 28: 73–80.",
      "volume": "28",
      "year": "2013"
    },
    {
      "author": "O Semler",
      "first-page": "183",
      "journal-title": "J Musculoskelet Neuronal Interact",
      "key": "BFejhg2013198_CR16",
      "unstructured": "Semler O, Netzer C, Hoyer-Kuhn H, Becker J, Eysel P, Schoenau E : First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI. J Musculoskelet Neuronal Interact 2012; 12: 183–188.",
      "volume": "12",
      "year": "2012"
    },
    {
      "DOI": "10.1136/jmg.16.2.101",
      "author": "DO Sillence",
      "doi-asserted-by": "publisher",
      "first-page": "101",
      "journal-title": "J Med Genet",
      "key": "BFejhg2013198_CR17",
      "unstructured": "Sillence DO, Senn A, Danks DM : Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979; 16: 101–116.",
      "volume": "16",
      "year": "1979"
    },
    {
      "DOI": "10.1634/stemcells.2007-0466",
      "author": "F Li",
      "doi-asserted-by": "publisher",
      "first-page": "3183",
      "journal-title": "Stem Cells",
      "key": "BFejhg2013198_CR18",
      "unstructured": "Li F, Wang X, Niyibizi C : Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation. Stem Cells 2007; 25: 3183–3193.",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1182/blood-2007-08-105809",
      "author": "PV Guillot",
      "doi-asserted-by": "publisher",
      "first-page": "1717",
      "journal-title": "Blood",
      "key": "BFejhg2013198_CR19",
      "unstructured": "Guillot PV, Abass O, Bassett JH et al: Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 2008; 111: 1717–1725.",
      "volume": "111",
      "year": "2008"
    },
    {
      "DOI": "10.1182/blood-2008-12-195859",
      "author": "C Panaroni",
      "doi-asserted-by": "publisher",
      "first-page": "459",
      "journal-title": "Blood",
      "key": "BFejhg2013198_CR20",
      "unstructured": "Panaroni C, Gioia R, Lupi A et al: In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 2009; 114: 459–468.",
      "volume": "114",
      "year": "2009"
    },
    {
      "DOI": "10.1182/blood.V97.5.1227",
      "author": "EM Horwitz",
      "doi-asserted-by": "publisher",
      "first-page": "1227",
      "journal-title": "Blood",
      "key": "BFejhg2013198_CR21",
      "unstructured": "Horwitz EM, Prockop DJ, Gordon PL et al: Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001; 97: 1227–1231.",
      "volume": "97",
      "year": "2001"
    },
    {
      "DOI": "10.1097/01.TP.0000159029.48678.93",
      "author": "K Le Blanc",
      "doi-asserted-by": "publisher",
      "first-page": "1607",
      "journal-title": "Transplantation",
      "key": "BFejhg2013198_CR22",
      "unstructured": "Le Blanc K, Gotherstrom C, Ringden O et al: Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005; 79: 1607–1614.",
      "volume": "79",
      "year": "2005"
    },
    {
      "DOI": "10.3109/14653249.2010.507330",
      "author": "DJ Prockop",
      "doi-asserted-by": "publisher",
      "first-page": "576",
      "journal-title": "Cytotherapy",
      "key": "BFejhg2013198_CR23",
      "unstructured": "Prockop DJ, Brenner M, Fibbe WE et al: Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 2010; 12: 576–578.",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nbt831",
      "author": "AL Jackson",
      "doi-asserted-by": "publisher",
      "first-page": "635",
      "journal-title": "Nat Biotechnol",
      "key": "BFejhg2013198_CR24",
      "unstructured": "Jackson AL, Bartz SR, Schelter J et al: Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 2003; 21: 635–637.",
      "volume": "21",
      "year": "2003"
    },
    {
      "DOI": "10.1074/jbc.274.53.37923",
      "author": "A Forlino",
      "doi-asserted-by": "publisher",
      "first-page": "37923",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2013198_CR25",
      "unstructured": "Forlino A, Porter FD, Lee EJ, Westphal H, Marini JC : Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice. J Biol Chem 1999; 274: 37923–37931.",
      "volume": "274",
      "year": "1999"
    },
    {
      "DOI": "10.1016/j.ab.2004.07.018",
      "author": "JT Chang",
      "doi-asserted-by": "publisher",
      "first-page": "199",
      "journal-title": "Anal Biochem",
      "key": "BFejhg2013198_CR26",
      "unstructured": "Chang JT : An economic and efficient method of RNAi vector constructions. Anal Biochem 2004; 334: 199–200.",
      "volume": "334",
      "year": "2004"
    },
    {
      "DOI": "10.1038/cgt.2009.89",
      "author": "J Rousseau",
      "doi-asserted-by": "publisher",
      "first-page": "387",
      "journal-title": "Cancer Gene Ther",
      "key": "BFejhg2013198_CR27",
      "unstructured": "Rousseau J, Escriou V, Perrot P et al: Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models. Cancer Gene Ther 2010; 17: 387–397.",
      "volume": "17",
      "year": "2010"
    },
    {
      "DOI": "10.1073/pnas.232688199",
      "author": "XF Qin",
      "doi-asserted-by": "publisher",
      "first-page": "183",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2013198_CR28",
      "unstructured": "Qin XF, An DS, Chen IS, Baltimore D : Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 2003; 100: 183–188.",
      "volume": "100",
      "year": "2003"
    },
    {
      "DOI": "10.1038/sj.onc.1210492",
      "author": "C Chipoy",
      "doi-asserted-by": "publisher",
      "first-page": "6653",
      "journal-title": "Oncogene",
      "key": "BFejhg2013198_CR29",
      "unstructured": "Chipoy C, Brounais B, Trichet V et al: Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53. Oncogene 2007; 26: 6653–6664.",
      "volume": "26",
      "year": "2007"
    },
    {
      "DOI": "10.1002/pmic.200600919",
      "author": "A Forlino",
      "doi-asserted-by": "publisher",
      "first-page": "1877",
      "journal-title": "Proteomics",
      "key": "BFejhg2013198_CR30",
      "unstructured": "Forlino A, Tani C, Rossi A et al: Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta. Proteomics 2007; 7: 1877–1891.",
      "volume": "7",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.matbio.2007.06.005",
      "author": "A Forlino",
      "doi-asserted-by": "publisher",
      "first-page": "604",
      "journal-title": "Matrix Biol",
      "key": "BFejhg2013198_CR31",
      "unstructured": "Forlino A, Kuznetsova NV, Marini JC, Leikin S : Selective retention and degradation of molecules with a single mutant alpha1(I) chain in the Brtl IV mouse model of OI. Matrix Biol 2007; 26: 604–614.",
      "volume": "26",
      "year": "2007"
    },
    {
      "DOI": "10.1002/stem.1107",
      "author": "R Gioia",
      "doi-asserted-by": "publisher",
      "first-page": "1465",
      "journal-title": "Stem Cells",
      "key": "BFejhg2013198_CR32",
      "unstructured": "Gioia R, Panaroni C, Besio R et al: Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy. Stem Cells 2012; 30: 1465–1476.",
      "volume": "30",
      "year": "2012"
    },
    {
      "DOI": "10.1093/nar/25.17.3451",
      "author": "G Grassi",
      "doi-asserted-by": "publisher",
      "first-page": "3451",
      "journal-title": "Nucleic Acids Res",
      "key": "BFejhg2013198_CR33",
      "unstructured": "Grassi G, Forlino A, Marini JC : Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects. Nucleic Acids Res 1997; 25: 3451–3458.",
      "volume": "25",
      "year": "1997"
    },
    {
      "DOI": "10.1086/383252",
      "author": "WA Cabral",
      "doi-asserted-by": "publisher",
      "first-page": "752",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg2013198_CR34",
      "unstructured": "Cabral WA, Marini JC : High proportion of mutant osteoblasts is compatible with normal skeletal function in mosaic carriers of osteogenesis imperfecta. Am J Hum Genet 2004; 74: 752–760.",
      "volume": "74",
      "year": "2004"
    },
    {
      "DOI": "10.1172/JCI118434",
      "author": "Q Wang",
      "doi-asserted-by": "publisher",
      "first-page": "448",
      "journal-title": "J Clin Invest",
      "key": "BFejhg2013198_CR35",
      "unstructured": "Wang Q, Marini JC : Antisense oligodeoxynucleotides selectively suppress expression of the mutant alpha 2(I) collagen allele in type IV osteogenesis imperfecta fibroblasts. A molecular approach to therapeutics of dominant negative disorders. J Clin Invest 1996; 97: 448–454.",
      "volume": "97",
      "year": "1996"
    },
    {
      "DOI": "10.1093/nar/28.20.4013",
      "author": "PA Dawson",
      "doi-asserted-by": "publisher",
      "first-page": "4013",
      "journal-title": "Nucleic Acids Res",
      "key": "BFejhg2013198_CR36",
      "unstructured": "Dawson PA, Marini JC : Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts. Nucleic Acids Res 2000; 28: 4013–4020.",
      "volume": "28",
      "year": "2000"
    },
    {
      "DOI": "10.1038/mt.2011.263",
      "author": "GR Rettig",
      "doi-asserted-by": "publisher",
      "first-page": "483",
      "journal-title": "Mol Ther",
      "key": "BFejhg2013198_CR37",
      "unstructured": "Rettig GR, Behlke MA : Progress toward in vivo use of siRNAs-II. Mol Ther 2012; 20: 483–512.",
      "volume": "20",
      "year": "2012"
    },
    {
      "DOI": "10.1371/journal.pgen.0020140",
      "author": "DS Schwarz",
      "doi-asserted-by": "publisher",
      "first-page": "e140",
      "journal-title": "PLoS Genet",
      "key": "BFejhg2013198_CR38",
      "unstructured": "Schwarz DS, Ding H, Kennington L et al: Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet 2006; 2: e140.",
      "volume": "2",
      "year": "2006"
    },
    {
      "DOI": "10.1371/journal.pone.0002248",
      "author": "Y Ohnishi",
      "doi-asserted-by": "publisher",
      "first-page": "e2248",
      "journal-title": "PLoS One",
      "key": "BFejhg2013198_CR39",
      "unstructured": "Ohnishi Y, Tamura Y, Yoshida M, Tokunaga K, Hohjoh H : Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi. PLoS One 2008; 3: e2248.",
      "volume": "3",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S0092-8674(03)00759-1",
      "author": "DS Schwarz",
      "doi-asserted-by": "publisher",
      "first-page": "199",
      "journal-title": "Cell",
      "key": "BFejhg2013198_CR40",
      "unstructured": "Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD : Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115: 199–208.",
      "volume": "115",
      "year": "2003"
    },
    {
      "DOI": "10.1038/nchembio839",
      "author": "D Bumcrot",
      "doi-asserted-by": "publisher",
      "first-page": "711",
      "journal-title": "Nat Chem Biol",
      "key": "BFejhg2013198_CR41",
      "unstructured": "Bumcrot D, Manoharan M, Koteliansky V, Sah DW : RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2006; 2: 711–719.",
      "volume": "2",
      "year": "2006"
    },
    {
      "DOI": "10.1242/jcs.068833",
      "author": "KY Tsang",
      "doi-asserted-by": "publisher",
      "first-page": "2145",
      "journal-title": "J Cell Sci",
      "key": "BFejhg2013198_CR42",
      "unstructured": "Tsang KY, Chan D, Bateman JF, Cheah KS : In vivo cellular adaptation to ER stress: survival strategies with double-edged consequences. J Cell Sci 2010; 123: 2145–2154.",
      "volume": "123",
      "year": "2010"
    },
    {
      "DOI": "10.1002/(SICI)1096-9896(199802)184:2\u003c212::AID-PATH996\u003e3.0.CO;2-Z",
      "author": "T Kojima",
      "doi-asserted-by": "publisher",
      "first-page": "212",
      "journal-title": "J Pathol",
      "key": "BFejhg2013198_CR43",
      "unstructured": "Kojima T, Miyaishi O, Saga S, Ishiguro N, Tsutsui Y, Iwata H : The retention of abnormal type I procollagen and correlated expression of HSP 47 in fibroblasts from a patient with lethal osteogenesis imperfecta. J Pathol 1998; 184: 212–218.",
      "volume": "184",
      "year": "1998"
    },
    {
      "DOI": "10.1126/science.1171242",
      "author": "N Cartier",
      "doi-asserted-by": "publisher",
      "first-page": "818",
      "journal-title": "Science",
      "key": "BFejhg2013198_CR44",
      "unstructured": "Cartier N, Hacein-Bey-Abina S, Bartholomae CC et al: Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009; 326: 818–823.",
      "volume": "326",
      "year": "2009"
    },
    {
      "DOI": "10.1182/blood-2010-09-306761",
      "author": "A Biffi",
      "doi-asserted-by": "publisher",
      "first-page": "5332",
      "journal-title": "Blood",
      "key": "BFejhg2013198_CR45",
      "unstructured": "Biffi A, Bartolomae CC, Cesana D et al: Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. Blood 2011; 117: 5332–5339.",
      "volume": "117",
      "year": "2011"
    },
    {
      "DOI": "10.1093/nar/gkr1214",
      "author": "P Perez-Pinera",
      "doi-asserted-by": "publisher",
      "first-page": "3741",
      "journal-title": "Nucleic Acids Res",
      "key": "BFejhg2013198_CR46",
      "unstructured": "Perez-Pinera P, Ousterout DG, Brown MT, Gersbach CA : Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases. Nucleic Acids Res 2012; 40: 3741–3752.",
      "volume": "40",
      "year": "2012"
    }
  ],
  "reference-count": 46,
  "references-count": 46,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2013198"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta"
  ],
  "type": "journal-article",
  "volume": "22"
}